Sonke Pharmaceuticals

Name

Sonke Pharmaceuticals

Website

https://sonkepharmaceuticals.co.za

Company type

Private

Founded year

2006

Headcount range

101–250 employees

Short description

Sonke Pharmaceuticals is a South African generic and antiretroviral medication manufacturer founded in 2006 and headquartered in Centurion. The privately held company, with 101–250 employees, serves domestic pharmaceutical markets focused on accessible HIV/AIDS and generic treatments.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals & Antiretroviral Medications

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

Keywords

• Generic medications
• Antiretroviral therapy
• Pharmaceutical manufacturing
• Generic pharmaceuticals
• HIV/AIDS treatment

Headquarters

HQ city

Centurion

HQ country

South Africa

HQ region

Africa

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Sonke Pharmaceuticals is a South African pharmaceutical manufacturer that develops and supplies generic medications and antiretroviral (ARV) drugs. The company focuses on producing affordable essential medicines and ARV therapies, primarily serving the South African healthcare market, including HIV/AIDS treatment programs. It operates as a private for-profit entity with 101–250 employees.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Medications Generic pharmaceutical medicines produced by Sonke Pharmaceuticals, sold to South African healthcare buyers including wholesalers, hospitals, clinics, and government health programs as cost-effective alternatives to branded essential medicines.
• Antiretroviral (ARV) Medications Antiretroviral drugs for HIV/AIDS treatment produced by Sonke Pharmaceuticals, intended for South African public health programs, hospitals, clinics, and pharmacy channels serving HIV-positive patients.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Hetero Labs: Indian-headquartered pharmaceutical company with one of the largest generic ARV manufacturing capacities globally and broad WHO prequalification. Active participant in African ARV tenders and a relevant incumbent competitor.
• Aurobindo Pharma: Large Indian generic manufacturer with WHO-prequalified ARV dossiers and significant export volumes into African public-sector programmes. Competes with Sonke for tender share in the African ARV category.
• Viatris (formerly Mylan): Global generic and specialty pharmaceutical company with a substantial ARV franchise inherited from Mylan and a meaningful African commercial footprint. Broad incumbent competitor in the generic ARV tender market.
• Teva Pharmaceutical Industries: Global generics leader with a meaningful presence across African markets, including in antiretroviral and chronic-disease categories. Broad incumbent competing with regional generics manufacturers for tender volume.
• Macleods Pharmaceuticals: Indian generic manufacturer with a major ARV franchise and WHO-prequalified product lines supplying African public-health programmes. Comparable on ARV category even though it does not focus specifically on South Africa.

Direct peers

• Cipla: Indian-headquartered global pharmaceutical company and one of the world's largest suppliers of antiretroviral medications, including significant ARV sales into South Africa and the broader African public sector. Directly comparable on ARV category and generic platform.
• Aspen Pharmacare: Africa's largest generic pharmaceutical manufacturer headquartered in South Africa, producing ARVs and a broad generic portfolio. Most directly comparable to Sonke by geography, therapeutic category, and customer base (South African government tenders).
• Adcock Ingram: South African pharmaceutical company with a generics and prescription portfolio serving the local public and private markets. Comparable by geography and broad generic-pharma business model, though a more diversified portfolio than a pure-play ARV/generic specialist.

Emerging players

• Strides Pharma Science: Indian generic manufacturer with a portfolio of ARV and chronic-disease products active in African markets. Comparable on generic platform and emerging-market distribution model, though smaller than top-tier ARV players.
• Lupin Pharmaceuticals: Indian-headquartered global generic pharmaceutical company with growing African and emerging-market exposure. Compares on generic-pharma business model and emerging-market GTM, though ARV is not its primary franchise.

Market position

Customer concentration

• LinkedInlinkedin.com/company/sonke-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonke Pharmaceuticals